Antiapoptotic Bcl-2 family members interact with inositol trisphosphate receptor (InsP 3 R) Ca 2+ release channels in the endoplasmic reticulum to modulate Ca 2+ signals that affect cell viability. However, the molecular details and consequences of their interactions are unclear. Here, we found that Bcl-x L activates single InsP 3 R channels with a biphasic concentration dependence. The Bcl-x L Bcl-2 homology 3 (BH3) domain-binding pocket mediates both high-affinity channel activation and low-affinity inhibition. Bcl-x L activates channel gating by binding to two BH3 domain-like helices in the channel carboxyl terminus, whereas inhibition requires binding to one of them and to a previously identified Bcl-2 interaction site in the channelcoupling domain. Disruption of these interactions diminishes cell viability and sensitizes cells to apoptotic stimuli. Our results identify BH3-like domains in an ion channel and they provide a unifying model of the effects of antiapoptotic Bcl-2 proteins on the InsP 3 R that play critical roles in Ca 2+ signaling and cell viability.
Antiapoptotic Bcl-2 family members interact with inositol trisphosphate receptor (InsP 3 R) Ca 2+ release channels in the endoplasmic reticulum to modulate Ca 2+ signals that affect cell viability. However, the molecular details and consequences of their interactions are unclear. Here, we found that Bcl-x L activates single InsP 3 R channels with a biphasic concentration dependence. The Bcl-x L Bcl-2 homology 3 (BH3) domain-binding pocket mediates both high-affinity channel activation and low-affinity inhibition. Bcl-x L activates channel gating by binding to two BH3 domain-like helices in the channel carboxyl terminus, whereas inhibition requires binding to one of them and to a previously identified Bcl-2 interaction site in the channelcoupling domain. Disruption of these interactions diminishes cell viability and sensitizes cells to apoptotic stimuli. Our results identify BH3-like domains in an ion channel and they provide a unifying model of the effects of antiapoptotic Bcl-2 proteins on the InsP 3 R that play critical roles in Ca 2+ signaling and cell viability.
Bcl-2 | ion channel | calcium | apoptosis | mitochondria T he inositol trisphosphate receptors (InsP 3 R) are a family of intracellular cation channels that release Ca 2+ from the endoplasmic reticulum (ER) in response to a variety of extracellular stimuli (1) . Three InsP 3 R isoforms are ubiquitously expressed and regulate diverse cell processes, including cell viability (1) . Activation of the channels by InsP 3 elicits changes in cytoplasmic Ca 2+ concentration ([Ca 2+ ] i ) that provide versatile signals to regulate molecular processes with high spatial and temporal fidelity (1) . Regions of close proximity to mitochondria enable localized Ca 2+ release events to be transduced to mitochondria (2, 3) . Ca 2+ released from the ER during cell stimulation modulates activities of effector molecules and is taken up by mitochondria to stimulate oxidative phosphorylation and enhance ATP production (4) (5) (6) to match energetic supply with enhanced demand. In addition, cells in vivo are constantly exposed to low levels of circulating hormones, transmitters, and growth factors that bind to plasma membrane receptors to provide a background level of cytoplasmic InsP 3 (7) that generates low-level stochastic InsP 3 R-mediated localized or propagating [Ca 2+ ] i signals (8) (9) (10) . Such signals also play an important role in maintenance of cellular bioenergetics (8) . Nevertheless, under conditions of cell stress the close proximity of mitochondria to Ca 2+ release sites may result in mitochondrial Ca 2+ overload and initiate Ca 2+ -dependent forms of cell death, including necrosis and apoptosis (11) (12) (13) . It has been suggested that high levels of ER Ca 2+ (14) (15) (16) and enhanced activity of the InsP 3 R (17-19) promote cell death by providing a higher quantity of released Ca 2+ to mitochondria (3, 20, 21) .
Protein interactions modulate the magnitude and quality of InsP 3 R-mediated [Ca 2+ ] i signals that regulate apoptosis and cell viability. Notable in this regard is the Bcl-2 protein family. Proapoptotic Bcl-2-related proteins Bax and Bak initiate cytochrome C release from mitochondria in response to diverse apoptotic stimuli, whereas antiapoptotic Bcl-2-related proteins, including Bcl-2 and Bcl-x L , antagonize Bax/Bak by forming heterodimers that prevent their oligomerization and apoptosis initiation (22, 23) . Heterodimerization is mediated by interactions of proapoptotic Bcl-2 homology 3 (BH3) domains with a hydrophobic groove on the surface of antiapoptotic Bcl-2 proteins (23) that is a therapeutic target in diseases, including cancer (22) . Whereas a central feature of molecular models of apoptosis is the control of outer mitochondrial membrane permeability by Bcl-2-related proteins, a substantial body of evidence has demonstrated that these proteins localize to the ER (24, 25) , bind to InsP 3 Rs (26) (27) (28) (29) (30) (31) (32) and, by modulating InsP 3 R-mediated Ca 2+ release, regulate ERmediated cell death and survival (15, 27, (32) (33) (34) . Nevertheless, a unified understanding of the detailed molecular mechanisms by which Bcl-2 family proteins interact with and regulate InsP 3 R channel activity is lacking. The Bcl-2 family member homolog NrZ interacts with the amino-terminal InsP 3 -binding region via its helix 1 BH4 domain and inhibits Ca 2+ release (28) . Bcl-2 also interacts with the InsP 3 R (26) via its BH4 domain (35) , but in contrast it associates with a region in the central coupling domain (35) . Whereas this interaction also inhibits Ca 2+ release (26) , Bok interacts with the channel 500 residues C-terminal to the Bcl-2 binding sequence via its BH4 domain but does not affect Ca 2+ release (29) . Conversely, the Bcl-x L BH4 domain may lack this interaction (36) . Inhibition of the Bcl-2 BH4 domain interaction with the channel enhanced InsP 3 R-mediated Ca 2+ signals and apoptosis sensitivity in white blood cells (18, 35, 37) .
Significance Changes in Ca
2+ concentration in the cell play important roles in cell life and death decisions. Antiapoptotic Bcl-2 family proteins help protect cells from dying by interacting with proteins at mitochondria and endoplasmic reticulum. At the endoplasmic reticulum, antiapoptotic Bcl-2 proteins interact with InsP 3 R Ca 2+ channels that release Ca 2+ into the cytoplasm. However, it is controversial how they interact with the InsP 3 R, as well as the functional consequences of the interactions. We found that antiapoptotic Bcl-x L interacts with InsP 3 Rs by unique mechanisms that change the activity of the channel depending on its concentration. We also found that disrupting these interactions diminishes cell viability. Our results provide a unifying model of the effects of antiapoptotic Bcl-2 proteins on the InsP 3 R.
However, it is unclear if Bcl-2 inhibits Ca 2+ signaling directly by binding to the channel or if it acts indirectly, as a hub in a protein complex that influences channel phosphorylation (38) . Conversely, we demonstrated that Bcl-x L , Bcl-2, and Mcl-1 bind to the carboxyl (C)-terminus of all three InsP 3 R isoforms, and showed that these interactions activated single InsP 3 R channels and promoted InsP 3 R-mediated Ca 2+ release and apoptosis resistance (27, 31, 32) . Furthermore, Bcl-x L mediates an interaction of oncogenic K-RAS with the InsP 3 R C terminus that regulates its biochemical and functional interaction and cell survival (39) . However, the molecular details of the interactions of antiapoptotic protein with the InsP 3 R C terminus are unknown. Furthermore, the relationship between Bcl-2 family protein binding in the coupling domain and C terminus is unclear. Thus, the mechanisms whereby Bcl-2 and Bcl-x L affect InsP 3 R activity and the effects of this modulation on cell viability remain to be determined.
Here, we used single-channel electrophysiology of native ER membranes to explore the detailed mechanisms of the effects of Bcl-x L on the InsP 3 R, and the role of this interaction on cell viability. Surprisingly, our results reveal that whereas Bcl-x L activates the channel at low concentrations, it inhibits it at higher concentrations, resulting in a biphasic response of channel activation on [Bcl-x L ]. Remarkably, the Bcl-x L BH3 domain-binding pocket is required for both effects. Low [Bcl-x L ] activates the channel by simultaneous binding to two BH3 domain-like helices in the channel C terminus, whereas channel inhibition at high [Bcl-x L ] requires binding to only one of them and to a site previously identified as the Bcl-2 binding site in the channelcoupling domain. Disruption of these interactions diminishes cell viability. Our results provide a unifying model of the effects of antiapoptotic Bcl-2 proteins on the InsP 3 R that play critical roles in Ca 2+ signaling and cell viability.
Results
Bcl-x L Binds to Dual BH3-Like Domains in the InsP 3 R Carboxyl Terminus.
The InsP 3 R consists of a 600-residue N-terminal InsP 3 binding domain, a cytoplasmic region (coupling domain) that links it to the transmembrane pore region that contains six transmembrane (TM) helices, and a cytoplasmic C-terminal tail of ∼175 amino acids ( Fig. 1A) (1). The strength of the interaction of Bcl-x L with a region spanning from the TM5-TM6 linker to the C terminus (residues 2,512-2,750) is quantitatively equivalent to that of the fulllength channel (27, 31) . To define Bcl-x L binding determinants within this region, GST-fusion proteins (Fig. 1B) were immobilized on glutathione beads, the quantities of beads were titrated, and the amounts of GST-InsP 3 R fragments used for pull-down experiments as well as the concentrations of Bcl-x L were adjusted to equivalent levels. Bcl-x L bound to a construct containing TM6 and the C terminus (TM6+C; residues 2,571-2,750) as efficiently as to the longer construct used in refs. 27 and 31. However, a shorter construct that encompassed the terminal 7 residues of TM6 and the remaining C terminus (C-term; residues 2,589-2,750) bound Bcl-x L less efficiently (Fig. 1B) . The TM6 helix is predicted to form the channel gate near residue G2586 (Fig. 1A) and to extend beyond the membrane into the cytoplasm. Distal to this helix, the remaining C terminus is predicted to contain three additional helices (H2-H4). We defined H1 as the helix containing TM6 and the 14 subsequent residues. Constructs with either H1 (ΔH1) or H4 (ΔH4) deleted bound Bcl-x L (Fig. 1B) , whereas one encompassing only helices 2 and 3 failed to bind Bcl-x L (Fig. 1B) , suggesting that both H1 and H4 bind Bcl-x L . In agreement, purified H1 or H4 peptides each interacted with GST-Bcl-x L (Fig. 1C) . The interaction of full-length InsP 3 R with Bcl-x L was inhibited by purified H1 or H4 proteins in the pull-down lysate (Fig. 1C) , indicating that, whereas either H1 or H4 can bind to Bcl-x L , both are required for strong binding to full-length InsP 3 R. This result also suggests that the C terminus is the dominant Bcl-x L binding region in the InsP 3 R. The affinity of the C terminus for Bcl-x L was estimated by quantitative comparisons with human Bax (hBax) binding to Bcl-x L . InsP 3 R TM6+C exhibited ∼10-fold greater binding than equivalent amounts of hBax (Fig. 1D) , suggesting an apparent affinity <50 nM (40, 41) . H1 bound to Bcl-x L with approximately the same affinity as hBax, whereas H4 bound with lower affinity (Fig. 1D and Fig. S1A ). Binding of TM6+C was greater than expected for simple additivity of H1 and H4 binding, suggesting that H1 and H4 contribute synergistically, in agreement with the conclusions from binding competition experiments.
We previously demonstrated that Bcl-x L binding to the InsP 3 R was competitively inhibited by either t-Bid or Bax (27) . Bax and t-Bid binding to Bcl-x L is mediated by their BH3 domains, amphipathic helical regions with a conserved arrangement of a key aspartic acid (Asp) and hydrophobic amino acids ( Fig. 2A) (23, 42) . We speculated that InsP 3 R interactions with Bcl-x L were similarly mediated by BH3-like sequences. Inspection of H1 and H4 revealed conserved BH3-like sequences in both ( Fig. 2A) . Binding of Bcl-x L to GST-Bax and GST-H1 is comparable, whereas binding to GST-H4 is weaker (Lower).
Synthetic H1 and H4 peptides that contained the putative BH3-like domains (Fig. 2B ) bound to both Bcl-x L and the antiapoptotic Bcl-2 protein, Mcl-1, as efficiently as full-length H1 and H4 helices (Fig. S1B) . Mutations of the key acidic residue and hydrophobic residue at P2 inhibit BH3 domain interactions (42) . Mutations to alanine (Ala) of Glu and P2 phenylalanine (Phe) in H1 (mH1) strongly inhibited Bcl-x L binding to TM6+C (Fig. 2C ). Similar mutations in H4 (mH4) inhibited binding to a lesser extent (Fig. 2C ), whereas simultaneous mutations in both H1 and H4 (mH1+4) inhibited binding to an extent observed for mutation in H1 only ( Fig. 2C ), again indicating a higher binding affinity for H1. Similar results were obtained using purified WT and mutant H1 and H4 peptides (Fig. 2D ). These biochemical results strongly suggest that Bcl-x L interacts with both H1 and H4 through BH3-like domains contained within each helix in the InsP 3 R channel C terminus. (1 μM) displayed a low open probability P o that was elevated by over an order of magnitude by inclusion of 1-μM purified recombinant full-length Bcl-x L in the pipette solution that bathes the cytoplasmic face of the channel (Fig. 3A ), in agreement with previous studies (27, 32) . The stimulation was dose-dependent, with an apparent K D of ∼700 nM and Hill coefficient of ∼2 (Fig.  3A) , suggesting cooperative activation, consistent with Bcl-x L binding to H1 and H4. Surprisingly, [Bcl-x L ] > ∼2 μM was less effective (Fig. 3A) . Consequently, the dose-dependence of Bcl-x L channel activation was biphasic, with half-maximal apparent inhibition observed at ∼3.5 μM with a Hill coefficient >3 (Fig. 3A) , indicating that apparent inhibition was also a cooperative process possibly reflecting multiple binding sites. To ensure that reduced efficacy of high [Bcl-x L ] to activate channel gating was caused by inhibition mediated by a low-affinity Bcl-x L binding sites, InsP 3 R activity was recorded with higher [InsP 3 ] (3 μM) that is more optimal for channel activity. Addition of 10 μM Bcl-x L inhibited channel gating under these conditions ( Fig. 3A) , demonstrating that Bcl-x L both activates and inhibits InsP 3 R channel gating, with high-affinity Bcl-x L binding activating the channel, and Bcl-x L binding to a low-affinity sites causing channel inhibition. At 1 μM Bcl-x L , channel activation was caused by an ∼25-fold decrease in the mean closed time. At 10 μM Bcl-x L , inhibition was caused by a threefold enhancement of the closed time and a twofold decrease in the channel open time (Fig. S2B) . Stable cell lines were generated that expressed InsP 3 R3 with mutations in either H4 (mH4-InsP 3 R3) or H1 (mH1-InsP 3 R3) that reduced Bcl-x L binding to the C terminus (Fig. 2C ). mH4-InsP 3 R3 had normal permeation and gating properties and responses to InsP 3 (Fig. S2A) . However, gating activation by Bcl-x L was completely abolished (Fig. 3B) . In contrast, high [Bcl-x L ] inhibition was unaffected (Fig. 3B) . Thus, Bcl-x L binding to H4 is required for channel activation, whereas inhibition is mediated by Bcl-x L binding to a different site. Channel gating activation by 1 μM Bcl-x L was also abolished in mH1-InsP 3 R3 (Fig. 3C) . Raising Bcl-x L to 10 μM still failed to activate the mutant channel (Fig. 3C ). mH1-InsP 3 R3 had normal sensitivity to InsP 3 ( Fig. S2A ) but had altered conductance and gating properties compared with the WT channel. Single-channel conductance was reduced from 545 pS to 54 ± 6 pS (n = 4) for the mutant. Reduced single-channel conductance was caused in part by neutralization of Asp at position 2,590, because a channel with only the D2590 mutation (D2590N-InsP 3 R3) exhibited reduced conductance (209 ± 3 pS; n = 11) (Fig. 3D) . Altered gating was primarily a consequence of mutating Phe2585, because this residue is predicted to be in close proximity to the channel gate (Fig. 1A) (44) and D2590N-InsP 3 R3 had normal P o , albeit with reduced open and closed times (τ o ∼ τ c = 2 ms) (Fig. 3D) . To minimize uncertainties associated with a channel with abnormal P o , we repeated experiments using D2590N-InsP 3 R3. D2590N-InsP 3 R3 had normal sensitivity to InsP 3 ( Fig. S2A ) but Bcl-x L failed to activate this mutant channel (Fig. 3D) . Furthermore, channel-gating inhibition by high [Bcl-x L ] was also abolished (Fig. 3D) . Taken together, these results indicate that Bcl-x L binding to both H4 and H1 are required for activation of channel gating, whereas lower affinity Bcl-x L inhibition requires binding to H1, but not to H4. In agreement, a H4 peptide-but not a mutant peptide mH4-blocked Bcl-x L channel activation but not inhibition (Fig. 3F) , whereas a H1 peptide-but not a mutant mH1-blocked both channel activation and inhibition (Fig. 3E) . of the InsP 3 R with purified full-length Bcl-x L proteins with either Gly138 or Arg139 mutated. As a control, we verified that G138A-Bcl-x L binding to hBax was significantly reduced compared with WT Bcl-x L (Fig. 4A) . Binding of G138A-Bcl-x L to TM6+C was profoundly inhibited compared with WT Bcl-x L (Fig. 4A) (P < 0.001), because of reduced binding at both H1 and H4 (Fig. S3) . The weakened biochemical interactions were manifested as significantly reduced potencies at the single-channel level. Whereas 1 μM WT Bcl-x L activated the channel gating robustly, 1 μM G138A-Bcl-x L was without effect (Fig. 4A) . However, higher concentrations activated gating (Fig. 4A) (P < 0.001) , indicating that the G138A mutation significantly reduced the binding affinity, consistent with the biochemical data. Similar data were obtained with R139Q-Bcl-x L (Fig. 4A) . These results suggest that the pocket that binds to BH3 domains of Bcl-2 family proteins also mediates biochemical and functional interactions of Bcl-x L with BH3-like domains in InsP 3 R. To test this further, we examined the effects of ABT-737, a small molecule that binds specifically in the Bcl-x L surface groove and prevents Bax and t-Bid binding (45) . ABT-737 inhibited the interaction of TM6+C with Bcl-x L with half-maximal concentration <100 nM (Fig. 4B) . Bcl-x L binding to H1 was less sensitive to ABT-737 than was H4 ( Fig. 4B) , consistent again with higher-affinity Bcl-x L binding to H1. ABT-737 (1 μM), but not inactive enantiomer, completely blocked channel activation by Bcl-x L (Fig. 4B) . Furthermore, ABT-737 also completely blocked high [Bcl-x L ] inhibition of channel gating (Fig. 4B) . Other pharmacological agents that disrupt Bcl-x L -BH3 domain interactions also blocked effects of Bcl-x L on InsP 3 R channel gating, including a synthetic Bax BH3 domain peptide and antimycin A (46) (Fig. 4C) . Together, these results implicate the BH3 binding groove in Bcl-x L in its biochemical and functional interactions with the InsP 3 R.
Additional Determinants in InsP 3 R Mediate Biochemical and Functional
Interactions with Bcl-x L . InsP 3 R channel activation by Bcl-x L requires binding to both H1 and H4 BH3-like domains, whereas channel inhibition by high Bcl-x L concentrations requires binding to H1 but H4 is not required. Low-affinity channel inhibition mediated by H1 is in apparent conflict with high-affinity biochemical binding of H1 to Bcl-x L (Fig. 1) . This finding suggested that low-affinity inhibition of channel gating may involve determinants in addition to the H1 BH3-like domain. Indeed, Bcl-x L bound weakly to full-length InsP 3 R with both H1 and H4 mutated ( Fig. 5 A and B) that was insensitive to ABT-737 (500 nM) (Fig.  5B ). Bcl-2 interacts with a region in the InsP 3 R coupling domain encompassing residues 1,347-1,426, referred to as 3a1 (37) . Bcl-x L bound to GST-3a1, but by comparison with Bcl-2, its binding was very much weaker (Fig. 5C ). Binding of Bcl-2 as well as residual binding of Bcl-x L to mH1+4-InsP 3 R3, although insensitive to ABT-737, were similarly inhibited by a peptide (Pep2; P2 in ref. 37 ) encompassing these residues (Fig. 5D ). Bcl-x L binding to the C terminus both activates and inhibits InsP 3 R channel activity (Fig. 3) , whereas only inhibition of Ca 2+ release has been reported for the interaction of Bcl-2 with the channel (17) . We hypothesized that if this region contributed additional binding determinants required for H1-mediated inhibition of channel gating, inclusion of Pep2 in the patch pipette solution would inhibit high [Bcl-x L ] inhibition of channel gating. Neither the peptide itself (10 μM) nor a scrambled control peptide had effects on channel gating in the absence of Bcl-x L , nor did either peptide affect 1 μM Bcl-x L activation (Fig. 5E ). In contrast, the peptide completely blocked the inhibitory effects of 10 μM Bcl-x L (Fig. 5E ). These results demonstrate that channel-gating inhibition by high [Bcl-x L ] requires binding to both the H1 BH3-like domain and a region (3a1) localized in the channel-coupling domain. The BH4 domain of Bcl-2 has been implicated in its binding to the InsP 3 R (35, 36) . It is possible that the BH4 domain of Bcl-x L also interacts with this channel region, because a synthetic Bcl-x L BH4 peptide reduced high [Bcl-x L ]-mediated channel inhibition (Fig. S4) .
InsP 3 R BH3-Like Domains Regulate Cell Viability. It was shown previously that Bcl-x L interaction with the InsP 3 R conferred apoptosis protection (27, 32) , likely by stimulating low-level Ca 2+ signaling that adapts cells to be resistant to stress (31) . Based on the results above, we hypothesized that Bcl-x L binding to InsP 3 R C-terminal BH3-like domains mediates this protection. To test this theory, stable DT40-KO cells expressing human Bcl-x L (27) were engineered to express WT InsP 3 R3 or mH4-InsP 3 R3 at equivalent levels and used in cell viability assays. Because of its altered conductance and gating properties, mH1-InsP 3 R3 was considered inappropriate in these assays. Cell death was triggered by 500 nM staurosporine (STS) in clonal lines that expressed comparable levels of Bcl-x L and WT vs. mutant InsP 3 R. With mH4-InsP 3 R3 and InsP 3 R3 expressed at levels comparable to WT cells (low expressers), STS induced cell death in both lines, but the mH4-InsP 3 R3 cells were more sensitive (Fig. 6A) . We also examined cells in which the WT and mutant InsP 3 R were overexpressed by >50-fold compared with normal ( Fig. 6A and Fig. S5 ). With much higher levels of InsP 3 R expression, Bcl-x L stimulation of channel gating may contribute to excessive Ca 2+ release to promote cell death. In this case, preventing Bcl-x L activation of InsP 3 R would be predicted to confer protection. In agreement, cell death was enhanced with increasing levels of strong overexpression of InsP 3 R3 (Fig. 6A) . Importantly, mutation of the channel H4 BH3-like domain conferred significant protection in cells expressing very high levels of InsP 3 R (Fig. 6A) .
To further explore the roles of Bcl-x L interaction with the channel H1 and H4 domains, we generated TAT fusion proteins of H1 and H4 peptides to facilitate their delivery into cells. Here, we reasoned that blocking the Bcl-x L -InsP 3 R interaction by peptide competition would reveal a role of these domains in normal cell viability. Neither H4-TAT (1 μM) nor the control peptides (scrambled H4 sequence) affected single InsP 3 R channel activity, whereas H4-TAT completely blocked activation by 1 μM Bcl-x L (Fig. 6B) , validating use of the peptides for cellular studies. Exposure of DT40 cells for 24 h to up to 4 μM TAT-H1 or TAT-H4 was without effect on cell viability (Fig. 6C) . In contrast, combined exposure to both TAT-H1 and TAT-H4 caused a dose-dependent loss of cell viability, with nearly complete cell killing at 4 μM (Fig.  6C) . In addition, although exposure to 1-5 μM TAT-H4 had no effect on viability, it strongly potentiated killing induced by 500 nM STS (Fig. 6C) . Similarly, simultaneous exposure to TAT-H1 and TAT-H4 peptides caused profound killing of human Raji lymphoblasts and MCF7 breast cells, whereas control peptides (scrambled H1 and H4 sequences) were without effect (Fig. 6D) . By flow cytometry analyses, cell death appeared to be distinct from apoptosis induced by STS, suggesting necrosis as the primary mechanism. TOTO-3 staining also suggested that necrosis was the major mechanism of cell death (Fig. 6D) . Taken together, these results suggest that the interaction between Bcl-x L and the H1/H4 domains of the InsP 3 R plays an important role in regulating cell viability.
Discussion
Antiapoptotic Bcl-2 family proteins Bcl-x L , Bcl-2, and Mcl-1 bind to the InsP 3 R Ca 2+ release channel C terminus, enhancing its channel activity and Ca 2+ release that affords ER-based apoptosis protection (27, 31, 32) . Bcl-x L interacts with the C terminus as strongly as with the full-length channel, suggesting that the C terminus represents the major binding determinant for Bcl-x L (27) and possibly the other antiapoptotic Bcl-2 proteins. Here, using biochemical approaches and single-channel electrophysiology, we have defined two distinct sites in the C terminus that mediate channel interactions with Bcl-x L . Furthermore, we defined determinants in Bcl-x L that mediate its interactions with both sites. Remarkably, the interactions are highly analogous to the interactions of proapoptotic Bcl-2 family proteins with Bclx L . Thus, we have identified two BH3-like domains in the InsP 3 R C terminus that interact with different affinities with the hydrophobic surface groove of Bcl-x L that binds BH3 domains in apoptotic proteins. Importantly, the biochemical results are strongly supported by electrophysiological analyses of the effects of WT and mutant Bcl-x L on the activities of single WT and mutant InsP 3 R channels. Interaction of Bcl-x L with the two sites has distinct functional effects, activating and inhibitory, which result in a biphasic concentration dependence of the effects of Bcl-x L on channel gating. Cell viability was compromised by interfering with the interactions, highlighting their importance. Of note, we found that a third binding site in the coupling domain, previously shown to interact with Bcl-2, participated in the inhibitory effects on channel gating of Bcl-x L binding to the C terminus, thereby providing a unifying framework for understanding the biochemical and functional interactions of antiapoptotic Bcl-2 family proteins with the InsP 3 R.
Various lines of evidence suggest that two regions in the InsP 3 R C terminus interact with Bcl-x L and that both are BH3 domain-like. First, the sequences of the interacting regions are reminiscent of BH3 domains. H1 and H4 have arrangements of critical negatively changed and surrounding hydrophobic residues that are present in all BH3 domains (42) . In the highaffinity H1 helix, the negatively charged residue is Asp, as in bone fide BH3 domains. In H4, it is Asp in the type 1 and Drosophila InsP 3 Rs, and Glu in types 2 and 3 InsP 3 R, which preserve the critical negative charge. The hydrophobic Leu at the P2 position is conserved, except in H1, where it is hydrophobic Phe. A notable difference in the sequence of the BH3-like domains in H1 and H4 is the absence of Gly immediately preceding the Asp. In H1 it is Ile and in H4 a Lys. Both residues are bulkier than Gly, the Lys introduces a charge, and both might be expected to diminish the binding affinity to Bcl-x L . Nevertheless, H1 bound to Bcl-x L with a higher apparent affinity than the Bax BH3 domain, suggesting that Ile in lieu of Gly is well accommodated by Bcl-x L . Lys in H4 is bulkier than Ile, which together with its charge, may account for the lower apparent affinity of H4. In agreement, mutation of Lys to Gly strongly enhanced the binding of H4 to Bcl-x L (Fig. S6) . Nevertheless, mutagenesis of the key Asp and hydrophobic P2 residue strongly inhibited binding of both helices to Bcl-x L . In addition, mutation of Arg139 in Bcl-x L , which interacts with the BH3 Asp, as well as Gly138, which also contributes to the binding interaction with BH3 domains, significantly reduced binding of each InsP 3 R helix with Bcl-x L . Finally, the biochemical interaction of the C terminus and each helix was strongly inhibited by ABT-737 and the Bax BH3 domain peptide, both of which bind specifically in the Bcl-x L surface groove. The biochemical data therefore strongly support the conclusion that interaction of Bcl-x L with the InsP 3 R is mediated by both H1 and H4 with the surface pocket in Bcl-x L in a manner that is highly reminiscent of the interactions of Bcl-x L with proapoptotic BH3 domains. Despite a similar strategy among Bcl-2 family proteins of BH3 domain binding to a surface hydrophobic groove, there is a high degree of specificity in the interactions (42, 47) . Furthermore, the binding pockets of some Bcl-2 family members, including Bcl-x L , have considerable conformational flexibility to accommodate different BH3 domains (48, 49) . Such structural flexibility may explain the interaction with the BH3-like domains in the InsP 3 R.
Unique to the study of Bcl-2 protein interactions, real-time single molecule recordings here validated the conclusions reached from biochemical studies, and provided insights into the functional implications of the interaction of Bcl-x L with the InsP 3 R. Using WT and mutant proteins and single-channel electrophysiology, we found a remarkable concordance between the biochemical and electrophysiological results. First, Bcl-x L both activated and inhibited the channel, suggesting that it interacts with the channel in at least two functional sites. High-affinity channel gating activation requires Bcl-x L binding to both H1 and H4, in agreement with the biochemical demonstration that the entire C terminus had the highest affinity for Bcl-x L . In contrast, low-affinity channel inhibition required binding to only the H1 helix. Thus, the biochemistry and electrophysiology suggest that H1 and H4 are both involved in the interactions of Bcl-x L with the InsP 3 R, with functional consequences. The single-channel recordings also provide strong support for the conclusion that the interactions of each helix are mediated by canonical BH3 domain interactions with the surface groove in Bcl-x L . Mutation of either Gly138 or Arg139 in the Bcl-x L binding pocket strongly reduced the ability of Bcl-x L to activate channel gating. Normal channel activation by the mutant Bcl-x L proteins was achieved when [Bcl-x L ] was raised by 10-to 40-fold. It is likely that the lower-affinity inhibitory site interaction was similarly affected by these mutations, but they were not observed because Bcl-x L could not be used in high-enough concentrations. This conclusion is supported by the effects of ABT-737, antimycin C, and the Bax BH3 domain peptide. All bind in the hydrophobic pocket in Bcl-x L and inhibited both channel activation and inhibition by Bcl-x L . In summary, single-channel electrophysiology provides strong validation of the biochemical studies. The studies demonstrate that the biochemical interactions have strong functional implications, and they support a model in which Bcl-x L interacts with two BH3-like domains in the channel C terminus.
After these experiments were completed, a high-resolution cryo-electron microscopy (cryo-EM) structure of rat InsP 3 R1 was solved (44) . The structure demonstrates that the TM6 helix extends into the cytoplasm, defining what we have referred to as H1. The side-chain of D2590 (2591 in the structure) points toward the cytoplasmic vestibule of the permeation pathway, in agreement with our studies that showed that neutralization of this residue reduced channel conductance, suggesting that D2590 contributes to the electrostatic environment in the cytoplasmic vestibule that promotes cation conduction. In the structure, F2585 (2586 in the structure) appears to form the channel gate. It is not obvious how Bcl-x L could access this site. However, the channel structure was solved in the absence of InsP 3 and Ca
2+
, and in a closed conformation whose relevance for the structure of an active liganded channel remains to be determined. Bcl-x L interaction with this region in an active channel suggests that the channel cytoplasmic vestibule must become more accessible during channel gating than is evident in the cryo-EM structure. Nevertheless, interaction with such a critical site in the channel would be predicted to influence channel gating, as we observe.
H4 is referred to as the C-terminal domain (CTD) in the cryo-EM structure (44) . It is an extended α-helix that has contacts with the InsP 3 binding domain and a ring of helical linker (LNK) domains, forming a connection between the InsP 3 binding domain and TM6. The LNK domain contains the two helices we referred to here as H2 and H3. The Bcl-x L binding determinants we defined here are located immediately proximal to the major LNK-interacting CTD residues. The CTD is in an ideal position to transmit conformational changes associated with Bcl-x L binding to both the InsP 3 -binding domain and the channel-gating machinery, and may therefore provide a structural basis for the role of H4 binding in Bcl-x L sensitization of the channel to InsP 3 (27) and in channel-gating activation. Nevertheless, our results indicate that simultaneous Bcl-x L binding to the H1 region is also required for channel activation, suggesting a model in which conformational changes in the CTD induced by Bcl-x L binding to H4 are transmitted to the channel regions that destabilize channel closed states only when Bcl-x L is simultaneously bound to TM6.
High [Bcl-x L ] inhibition of channel gating was independent of the CTD. Inhibition of InsP 3 R-mediated Ca 2+ release has been observed as a functional effect of Bcl-2 interaction with the channel (17) . There, the interaction determinants described are different from those defined here. The Bcl-2 BH4 domain, a helix localized on the opposite face of the protein from the surface groove, interacts with a 3a1 region in the coupling domain (35, 37) . We found residual binding of Bcl-x L to the channel after elimination of its binding to the C terminus, which was localized to the same 3a1 region. Although the affinity for Bcl-x L was much lower than that for Bcl-2, the interaction nevertheless appears to be critical for channel-gating inhibition by high [Bcl-x L ] because a peptide that blocks the (residual) interaction of both Bcl-2 and Bcl-x L blocked the ability of Bcl-x L to inhibit channel gating. Thus, high-affinity Bcl-x L binding to H1 and simultaneous low-affinity interaction with 3a1 accounts for channel-gating inhibition by high [Bcl-x L ]. Our results suggest a unifying framework that rationalizes previously discrepant results regarding the biochemical and functional implications of different antiapoptotic Bcl-2 family protein interactions with the InsP 3 R. It will be of interest to determine if inhibition of InsP 3 Rmediated Ca 2+ release by Bcl-2 requires its simultaneous binding to H1. Channel activation requires at least two Bcl-x L molecules to interact with a tetrameric InsP 3 R channel, because the interactions involve two sites (H1, H4) with the same binding site on Bcl-x L . In contrast, a single Bcl-x L molecule could possibly mediate channel inhibition, by binding H1 with its surface groove and 3a1 with another part of the molecule, perhaps the BH4 domain on the opposite surface.
The biphasic concentration dependence of effects of Bcl-x L on channel gating suggests that functional effects in cells will vary with expression levels and physical proximity of Bcl-x L and the InsP 3 R. A priori it might be expected that the high-affinity, activating effects of Bcl-x L will usually dominate. Because low-level constitutive InsP 3 R-mediated Ca 2+ release is essential for preserving normal bioenergetics under basal conditions (8), we expected that the interaction of Bcl-x L with H1 and H4 would provide resistance to stress and promote cell viability. With InsP 3 R expressed at approximately normal levels, intact H1 and H4 BH3-like domains play important roles in cell viability. In contrast, when InsP 3 R is grossly overexpressed, the domains sensitize cells to stress, possibly because of excessive Ca 2+ release that activates death pathways. Both results suggest that H1 and H4 play important roles in regulating the level of channel activity in vivo, and they indicate that antiapoptotic Bcl-2 protein InsP 3 R C-terminal interactions play important roles in regulating the channels under normal conditions in the cell types examined.
In summary, we have identified unique molecular interactions of Bcl-x L with the InsP 3 R that involves dual BH3-like domains in the C terminus of the channel. The interactions of the surface hydrophobic groove of Bcl-x L with these domains have both activating and inhibitory effects on channel gating. These interactions are important in regulating channel activity in vivo in a manner that strongly influences sensitivity to cell stress and cell viability. Because drugs such as ABT-737 that target BH3-Bcl-2 family protein interactions are being developed as cancer therapeutics, our results suggest an additional target, the interaction of Bcl-2 proteins with the InsP 3 R, that may influence their efficacy. Furthermore, ABT-737 inhibition of enhanced InsP 3 R-mediated Ca 2+ release in diabetic vascular smooth muscle cells (50) may suggest that this interaction could be targeted for other diseases as well.
Materials and Methods
Details regarding the sources of materials used, cell culture and generation of cell lines, plasmid construction and virus generation, protein and peptide expression, synthesis and purification, the sequences of peptides used, details regarding GST-fusion protein pull downs, fluorescence binding and Western blotting assays, cell viability assays, single-channel electrophysiology, and analyses and statistics are discussed in SI Materials and Methods.
